Document Detail


Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
MedLine Citation:
PMID:  7524463     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: This study examined the effect of long-term (mean, 19 months) treatment with clomipramine hydrochloride on cerebrospinal fluid (CSF) levels of several neuropeptides and monoamine metabolites in children and adolescents with obsessive-compulsive disorder. METHODS: The CSF levels of corticotropin-releasing hormone, vasopressin, somatostatin, and oxytocin and of the monoamine metabolites 5-hydroxyindoleacetic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol were measured in 17 children and adolescents with obsessive-compulsive disorder before and after long-term treatment with clomipramine. RESULTS: Treatment resulted in significant decreases in CSF levels of corticotropin-releasing hormone (mean +/- SD, 175 +/- 32 vs 152 +/- 25 pmol/L, P < .03) and vasopressin (mean +/- SD, 1.30 +/- 0.57 vs 0.86 +/- 0.54 pmol/L, P < .02) and a trend toward a decrease in somatostatin levels (mean +/- SD, 21.3 +/- 8.5 vs 15.3 +/- 9.8 pmol/L, P < .06). Treatment also significantly increased CSF oxytocin levels (mean +/- SD, 6.05 +/- 1.60 vs 6.70 +/- 1.44 pmol/L, P < .01). Significant changes in CSF monoamine metabolite levels with treatment included significant decreases in CSF levels of 5-hydroxyindoleacetic acid (mean +/- SD, 109 +/- 31 vs 77 +/- 23 pmol/mL, P < .001), CSF homovanillic acid (mean +/- SD, 273 +/- 111 vs 237 +/- 101 pmol/mL, P < .04), and 3-methoxy-4-hydroxyphenylglycol (mean +/- SD, 42.4 +/- 10.2 vs 36.1 +/- 4.8 pmol/L, P < .02) and a significant increase in the homovanillic acid-5-hydroxyindoleacetic acid ratio (mean +/- SD, 2.44 +/- 0.46 vs 3.42 +/- 0.84, P < .0001). CONCLUSIONS: These neuropeptide results coupled with evidence that central administration of corticotropin-releasing hormone, vasopressin, and somatostatin to laboratory animals increases arousal and acquisition of conditioned behaviors whereas central administration of oxytocin has opposite behavioral effects are consistent with a role for these neuropeptides in the pathophysiologic processes and pharmacologic treatment of obsessive-compulsive disorder.
Authors:
M Altemus; S E Swedo; H L Leonard; D Richter; D R Rubinow; W Z Potter; J L Rapoport
Related Documents :
7420023 - Central pyrogenic activity of muramyl dipeptide.
15191883 - In vivo muscle amino acid transport involves two distinct processes.
12889833 - Regioselective synthesis of kojic acid esters by bacillus subtilis protease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of general psychiatry     Volume:  51     ISSN:  0003-990X     ISO Abbreviation:  Arch. Gen. Psychiatry     Publication Date:  1994 Oct 
Date Detail:
Created Date:  1994-10-21     Completed Date:  1994-10-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372435     Medline TA:  Arch Gen Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  794-803     Citation Subset:  AIM; IM    
Affiliation:
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Clomipramine / pharmacology,  therapeutic use*
Corticotropin-Releasing Hormone / cerebrospinal fluid*,  physiology
Female
Homovanillic Acid / cerebrospinal fluid
Humans
Hydroxyindoleacetic Acid / cerebrospinal fluid
Male
Methoxyhydroxyphenylglycol / cerebrospinal fluid
Obsessive-Compulsive Disorder / cerebrospinal fluid*,  drug therapy,  physiopathology
Somatostatin / cerebrospinal fluid*,  physiology
Treatment Outcome
Vasopressins / cerebrospinal fluid*,  physiology
Chemical
Reg. No./Substance:
11000-17-2/Vasopressins; 303-49-1/Clomipramine; 306-08-1/Homovanillic Acid; 51110-01-1/Somatostatin; 534-82-7/Methoxyhydroxyphenylglycol; 54-16-0/Hydroxyindoleacetic Acid; 9015-71-8/Corticotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with To...
Next Document:  Detection of proliferating cell nuclear antigen in paraffin-embedded specimens is dependent on preem...